BACKGROUND: Between January 1993 and December 2003, 19 patients with familial prion diseases due to the D178N mutation were referred to the regional epidemiological registry for spongiform encephalopathies in the Basque Country in Spain, a small community of some 2,100,000 inhabitants. METHODS: Ten further patients belonging to the same pedigrees were retrospectively ascertained through neurological or neuropathological records. In four of the patients, the diagnosis was confirmed by analysing DNA obtained from paraffin blocks. In this article, we report on the clinical, genetic, and pathological features of the 23 patients carrying the D178N mutation confirmed by genetic molecular analysis. Haplotyping studies suggest a founder effect among Basque born families, explaining in part this unusually high incidence of the D178N mutation in a small community. Only two patients (8%) lack familial antecedents. RESULTS: We have observed a phenotypic variability even among homozygous 129MM patients. Our findings challenge the currently accepted belief that MM homozygosity in codon 129 is always related to a fatal familial insomnia (FFI) phenotype. Indeed, seven out of 17 patients with a 129MM genotype in this series presented with a Creutzfeldt-Jakob disease (CJD) clinicopathological picture. CONCLUSIONS: The considerable clinical and pathological overlapping observed among homozygous 129MM patients favours the view that FFI and CJD178 are the extremes of a spectrum rather than two discrete and separate entities. Other genetic or environmental factors apart from the polymorphism in codon 129 may play a role in determining the phenotypic expression of the D178N mutation in the PRNP gene.
BACKGROUND: Between January 1993 and December 2003, 19 patients with familial prion diseases due to the D178N mutation were referred to the regional epidemiological registry for spongiform encephalopathies in the Basque Country in Spain, a small community of some 2,100,000 inhabitants. METHODS: Ten further patients belonging to the same pedigrees were retrospectively ascertained through neurological or neuropathological records. In four of the patients, the diagnosis was confirmed by analysing DNA obtained from paraffin blocks. In this article, we report on the clinical, genetic, and pathological features of the 23 patients carrying the D178N mutation confirmed by genetic molecular analysis. Haplotyping studies suggest a founder effect among Basque born families, explaining in part this unusually high incidence of the D178N mutation in a small community. Only two patients (8%) lack familial antecedents. RESULTS: We have observed a phenotypic variability even among homozygous 129MM patients. Our findings challenge the currently accepted belief that MM homozygosity in codon 129 is always related to a fatal familial insomnia (FFI) phenotype. Indeed, seven out of 17 patients with a 129MM genotype in this series presented with a Creutzfeldt-Jakob disease (CJD) clinicopathological picture. CONCLUSIONS: The considerable clinical and pathological overlapping observed among homozygous 129MM patients favours the view that FFI and CJD178 are the extremes of a spectrum rather than two discrete and separate entities. Other genetic or environmental factors apart from the polymorphism in codon 129 may play a role in determining the phenotypic expression of the D178N mutation in the PRNP gene.
Authors: Y Taniwaki; H Hara; K Doh-Ura; I Murakami; H Tashiro; T Yamasaki; H Shigeto; K Arakawa; E Araki; T Yamada; T Iwaki; J Kira Journal: J Neurol Neurosurg Psychiatry Date: 2000-03 Impact factor: 10.154
Authors: E Lugaresi; R Medori; P Montagna; A Baruzzi; P Cortelli; A Lugaresi; P Tinuper; M Zucconi; P Gambetti Journal: N Engl J Med Date: 1986-10-16 Impact factor: 91.245
Authors: Gábor G Kovács; Gianriccardo Trabattoni; Johannes A Hainfellner; James W Ironside; Richard S G Knight; Herbert Budka Journal: J Neurol Date: 2002-11 Impact factor: 4.849
Authors: Juan J Zarranz; Anton Digon; Begoña Atarés; José M Arteagoitia; Nieves Carrera; Iñaki Fernández-Manchola; Manuel Fernández-Martínez; Covadonga Fernández-Maiztegui; Isabel Forcadas; Luis Galdos; Agustín Ibáñez; Elena Lezcano; José F Martí-Massó; María M Mendibe; Miguel Urtasun; Juan M Uterga; Nieves Saracibar; Fernando Velasco; Luis González de Galdeano Journal: Neuroepidemiology Date: 2004-09-24 Impact factor: 3.282
Authors: V Manetto; R Medori; P Cortelli; P Montagna; P Tinuper; A Baruzzi; G Rancurel; J J Hauw; J J Vanderhaeghen; P Mailleux Journal: Neurology Date: 1992-02 Impact factor: 9.910
Authors: L G Goldfarb; R B Petersen; M Tabaton; P Brown; A C LeBlanc; P Montagna; P Cortelli; J Julien; C Vital; W W Pendelbury Journal: Science Date: 1992-10-30 Impact factor: 47.728
Authors: E Sforza; P Montagna; P Tinuper; P Cortelli; P Avoni; F Ferrillo; R Petersen; P Gambetti; E Lugaresi Journal: Electroencephalogr Clin Neurophysiol Date: 1995-06
Authors: A T Reder; A S Mednick; P Brown; J P Spire; E Van Cauter; R L Wollmann; L Cervenàkovà; L G Goldfarb; A Garay; F Ovsiew Journal: Neurology Date: 1995-06 Impact factor: 9.910
Authors: Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind Journal: Cold Spring Harb Perspect Biol Date: 2018-05-01 Impact factor: 10.005
Authors: Ana B Rodríguez-Martínez; Miguel A Alfonso-Sánchez; José A Peña; Raquel Sánchez-Valle; Inga Zerr; Sabina Capellari; Miguel Calero; Juan J Zarranz; Marian M de Pancorbo Journal: Neurogenetics Date: 2008-03-18 Impact factor: 2.660
Authors: Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr Journal: Eur J Epidemiol Date: 2015-06-16 Impact factor: 8.082
Authors: Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-01 Impact factor: 3.568
Authors: Anna Krasnianski; Nicolas von Ahsen; Uta Heinemann; Bettina Meissner; Hans A Kretzschmar; Victor W Armstrong; Inga Zerr Journal: J Mol Neurosci Date: 2007-09-11 Impact factor: 3.444